These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 38897370)

  • 21. Intravenous Thrombolytics in the Treatment of Acute Ischemic Stroke.
    Alhadid K; Oliveira L; Etherton MR
    Curr Treat Options Cardiovasc Med; 2023; 25(1):15-28. PubMed ID: 36618509
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.
    Sbidian E; Chaimani A; Afach S; Doney L; Dressler C; Hua C; Mazaud C; Phan C; Hughes C; Riddle D; Naldi L; Garcia-Doval I; Le Cleach L
    Cochrane Database Syst Rev; 2020 Jan; 1(1):CD011535. PubMed ID: 31917873
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Intravenous Tenecteplase for Acute Ischemic Stroke Within 4.5-24 Hours of Onset (ROSE-TNK): A Phase 2, Randomized, Multicenter Study.
    Wang L; Dai YJ; Cui Y; Zhang H; Jiang CH; Duan YJ; Zhao Y; Feng YF; Geng SM; Zhang ZH; Lu J; Zhang P; Zhao LW; Zhao H; Ma YT; Song CG; Zhang Y; Chen HS
    J Stroke; 2023 Sep; 25(3):371-377. PubMed ID: 37608533
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Tenecteplase versus alteplase for the treatment of acute ischemic stroke: a meta-analysis of randomized controlled trials.
    Huang J; Zheng H; Zhu X; Zhang K; Ping X
    Ann Med; 2024 Dec; 56(1):2320285. PubMed ID: 38442293
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Outcomes with IV tenecteplase and IV alteplase for acute ischemic stroke with or without thrombectomy in real-world settings in the United States.
    Qureshi AI; Baskett WI; Bains NK; French BR; Siddiq F; Gomez CR; Shyu CR
    J Stroke Cerebrovasc Dis; 2023 Feb; 32(2):106898. PubMed ID: 36493706
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Symptomatic Intracranial Hemorrhage With Tenecteplase vs Alteplase in Patients With Acute Ischemic Stroke: The Comparative Effectiveness of Routine Tenecteplase vs Alteplase in Acute Ischemic Stroke (CERTAIN) Collaboration.
    Warach SJ; Ranta A; Kim J; Song SS; Wallace A; Beharry J; Gibson D; Cadilhac DA; Bladin CF; Kleinig TJ; Harvey J; Palanikumar L; Doss VT; Marescalco R; Fink JN; Tyson A; Schlick KH; Noh L; Wilson D; Figueroa S; Pech MA; Paletz LB; Lewis MK; Castro M; Sahlein DH; Lafranchise EF; Sandall J; Asif KS; Geraghty SR; Cullis PA; Malisch T; Neill TA; LaMonte MP; Campbell BCV; Wu TY
    JAMA Neurol; 2023 Jul; 80(7):732-738. PubMed ID: 37252708
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Tenecteplase versus alteplase for acute ischaemic stroke: a meta-analysis of phase III randomised trials.
    Xiong Y; Wang L; Li G; Yang KX; Hao M; Li S; Pan Y; Wang Y
    Stroke Vasc Neurol; 2023 Aug; ():. PubMed ID: 37640500
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Tenecteplase versus alteplase before mechanical thrombectomy: experience from a US healthcare system undergoing a system-wide transition of primary thrombolytic.
    Hendrix P; Collins MK; Griessenauer CJ; Goren O; Melamed I; Weiner GM; Dalal SS; Kole MJ; Noto A; Schirmer CM
    J Neurointerv Surg; 2023 Nov; 15(e2):e277-e281. PubMed ID: 36414389
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Endovascular thrombectomy without versus with different pre-intravenous thrombolysis in acute ischemic stroke: a network meta-analysis of randomized controlled trials.
    Guo S; Qin S; Tan S; Su H; Chen X
    Front Neurol; 2024; 15():1344961. PubMed ID: 38348167
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Intravenous thrombolysis with 0.9 mg/kg alteplase for acute ischaemic stroke: a network meta-analysis of treatment delay.
    Chen X; Shen Y; Huang C; Geng Y; Yu Y
    Postgrad Med J; 2020 Nov; 96(1141):680-685. PubMed ID: 31857497
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Tenecteplase vs. Alteplase for Intravenous Thrombolytic Therapy of Acute Ischemic Stroke: A Systematic Review and Meta-Analysis.
    Shen Z; Bao N; Tang M; Yang Y; Li J; Liu W; Jiang G
    Neurol Ther; 2023 Oct; 12(5):1553-1572. PubMed ID: 37552459
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Different Doses of Intravenous Tissue-Type Plasminogen Activator for Acute Ischemic Stroke: A Network Meta-Analysis.
    Li BH; Wang JH; Wang H; Wang DZ; Yang S; Guo FQ; Yu NW
    Front Neurol; 2022; 13():884267. PubMed ID: 35812086
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Efficacy and safety of tenecteplase in comparison to alteplase in acute ischemic stroke: A systematic review and meta-analysis of randomized controlled trials.
    Salamatullah HK; Bashrahil B; Alghamdi AM; Alsharm FS; Alkulli OA; Alzahrani Z; Alkhiri A; Alghamdi S; Makkawi S
    Clin Neurol Neurosurg; 2023 Oct; 233():107961. PubMed ID: 37713743
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A qualitative study of barriers and facilitators to using tenecteplase to treat acute ischemic stroke.
    Prasad S; Jones EM; Gebreyohanns M; Aguilera V; Olson DM; Anderson JA; Savitz SI; Flores SC; Warach SJ; Rhodes CE; Goldberg MP; Ifejika NL
    J Stroke Cerebrovasc Dis; 2024 Jan; 33(1):107458. PubMed ID: 37956644
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Off-Label Use of Tenecteplase for the Treatment of Acute Ischemic Stroke: A Systematic Review and Meta-analysis.
    Katsanos AH; Psychogios K; Turc G; Sacco S; de Sousa DA; De Marchis GM; Palaiodimou L; Filippou DK; Ahmed N; Sarraj A; Menon BK; Tsivgoulis G
    JAMA Netw Open; 2022 Mar; 5(3):e224506. PubMed ID: 35357458
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tenecteplase vs Alteplase Before Endovascular Therapy in Basilar Artery Occlusion.
    Alemseged F; Ng FC; Williams C; Puetz V; Boulouis G; Kleinig TJ; Rocco A; Wu TY; Shah D; Arba F; Kaiser D; Di Giuliano F; Morotti A; Sallustio F; Dewey HM; Bailey P; O'Brien B; Sharma G; Bush S; Dowling R; Diomedi M; Churilov L; Yan B; Parsons MW; Davis SM; Mitchell PJ; Yassi N; Campbell BCV;
    Neurology; 2021 Mar; 96(9):e1272-e1277. PubMed ID: 33408145
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tenecteplase and Alteplase for Thrombolysis of Acute Ischemic Stroke within 4.5 Hours: An Efficacy and Safety Study.
    Dhar N; Kumar M; Tiwari A; Desai I; Madhaw G; Kumar N
    Ann Indian Acad Neurol; 2022; 25(5):897-901. PubMed ID: 36561006
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Multicenter exploration of tenecteplase transition factors: A quantitative analysis.
    Prasad S; Jones EM; Gebreyohanns M; Kwon Y; Olson DM; Anderson JA; Savitz SI; Cruz-Flores S; Warach SJ; Rhodes CE; Goldberg MP; Ifejika NL
    J Stroke Cerebrovasc Dis; 2024 Apr; 33(4):107592. PubMed ID: 38266690
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Door to needle time trends after transition to tenecteplase: A Multicenter Texas stroke registry.
    Rodriguez N; Prasad S; Olson DM; Bandela S; Gealogo Brown G; Kwon Y; Gebreyohanns M; Jones EM; Ifejika NL; Stone S; Anderson JA; Savitz SI; Cruz-Flores S; Warach SJ; Goldberg MP; Birnbaum LA
    J Stroke Cerebrovasc Dis; 2024 Aug; 33(8):107774. PubMed ID: 38795796
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effectiveness and Safety of Tecneplase vs. Alteplase in the Acute Treatment of Ischemic Stroke.
    Estella Á; Pérez Ruiz M; Serrano JJ
    J Pers Med; 2022 Sep; 12(9):. PubMed ID: 36143310
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.